(kirstypargeter)

In the Legal’s Life Sciences, Pharmaceuticals & Health Care supplement, articles focus on the future of 3D printing in the industry, personal health technology and medical marijuana.

Click here to download the digital edition


The Future of 3D Printing in Pharma, Medical Devices
The concept seems like magic—a few strokes of a printer and a ­prescription medication or a ­customized medical device is available at your fingertips. Yet thanks to additive manufacturing, more commonly known as “3D printing,” what seems almost unimaginable is indeed reality. The popularity and utility of additive manufacturing is rapidly increasing across ­countless industries. Read more


Affordable Care Act Overpayment Rule: The Stakes Are High
Attorneys representing health care providers know well that our clients in the health care industry often dispute the adequacy of Medicare reimbursement. However, providers sometimes discover that they have been overpaid by Medicare. It may be a claim billed by them (or their billing agent) using a mistaken billing code, misidentification of the provider or otherwise based on an unintended mistake. Read more


Personal Health Technology and Issues Surrounding Health Data
Many consumers became skeptical of the privacy issues inherent in constant and unquestioning use of activity trackers in 2011, when Fitbit users unwittingly published the details of their physical—and sexual—activity histories online, searchable by user via standard search engines, (Kashmir Hill of Forbes, “Fitbit Moves Quickly After Users’ Sex Stats Exposed,” July 5, 2011). Read more


Post-Brexit Ramifications for Pharma, Life Sciences Industries
This article seeks to summarize what Brexit could mean for the U.K. and EU pharmaceutical and medical device sectors. The U.K. government is expected to invoke Article 50 of the Lisbon Treaty by notifying the EU Council of its intention to leave the EU in early 2017. If no agreement is reached within two years of the notification, then EU laws cease to apply in the U.K. The two-year period may only be extended if the European Council unanimously agrees. Read more


Substance Use Disorder Confidentiality Rules for a New Era of Care
According to the Center for Disease Control more than 120 Americans die every day as a result of drug overdose. Public exasperation with the opioid epidemic has helped raise the profile of treatment for substance use disorders (SUDs) and translated into political action. Read more


Implications of the Medical Marijuana Law for Health Care Providers
In April 2016, Pennsylvania enacted ground-breaking legislation on medical marijuana production and distribution that will have a far-reaching impact on the health care industry in this state, the Medical Marijuana Act, 35 P.S. Section 10231.101. Read more


‘Tincher’ and Prescription Medical Products Liability
As all products liability practitioners are aware by now, at the end of 2014, a watershed moment in Pennsylvania products liability law occurred when the Pennsylvania Supreme Court decided Tincher v. Omega Flex, 104 A.3d 328 (Pa. 2014). Read more

 

In the Legal’s Life Sciences, Pharmaceuticals & Health Care supplement, articles focus on the future of 3D printing in the industry, personal health technology and medical marijuana.

Click here to download the digital edition


The Future of 3D Printing in Pharma, Medical Devices
The concept seems like magic—a few strokes of a printer and a ­prescription medication or a ­customized medical device is available at your fingertips. Yet thanks to additive manufacturing, more commonly known as “3D printing,” what seems almost unimaginable is indeed reality. The popularity and utility of additive manufacturing is rapidly increasing across ­countless industries. Read more


Affordable Care Act Overpayment Rule: The Stakes Are High
Attorneys representing health care providers know well that our clients in the health care industry often dispute the adequacy of Medicare reimbursement. However, providers sometimes discover that they have been overpaid by Medicare. It may be a claim billed by them (or their billing agent) using a mistaken billing code, misidentification of the provider or otherwise based on an unintended mistake. Read more


Personal Health Technology and Issues Surrounding Health Data
Many consumers became skeptical of the privacy issues inherent in constant and unquestioning use of activity trackers in 2011, when Fitbit users unwittingly published the details of their physical—and sexual—activity histories online, searchable by user via standard search engines, (Kashmir Hill of Forbes, “Fitbit Moves Quickly After Users’ Sex Stats Exposed,” July 5, 2011). Read more


Post-Brexit Ramifications for Pharma, Life Sciences Industries
This article seeks to summarize what Brexit could mean for the U.K. and EU pharmaceutical and medical device sectors. The U.K. government is expected to invoke Article 50 of the Lisbon Treaty by notifying the EU Council of its intention to leave the EU in early 2017. If no agreement is reached within two years of the notification, then EU laws cease to apply in the U.K. The two-year period may only be extended if the European Council unanimously agrees. Read more


Substance Use Disorder Confidentiality Rules for a New Era of Care
According to the Center for Disease Control more than 120 Americans die every day as a result of drug overdose. Public exasperation with the opioid epidemic has helped raise the profile of treatment for substance use disorders (SUDs) and translated into political action. Read more


Implications of the Medical Marijuana Law for Health Care Providers
In April 2016, Pennsylvania enacted ground-breaking legislation on medical marijuana production and distribution that will have a far-reaching impact on the health care industry in this state, the Medical Marijuana Act, 35 P.S. Section 10231.101. Read more


‘Tincher’ and Prescription Medical Products Liability
As all products liability practitioners are aware by now, at the end of 2014, a watershed moment in Pennsylvania products liability law occurred when the Pennsylvania Supreme Court decided Tincher v. Omega Flex, 104 A.3d 328 ( Pa. 2014 ). Read more